As we move into 2026, several converging trends are set to create the most favorable buying conditions for surplus lab equipment in over a decade.
Three key factors are driving this shift:
- The conclusion of large-scale COVID-era funding programs—multi-year NIH, ARPA-H, and institutional grants awarded in 2020–2023 are reaching natural endpoints, releasing minimally used, high-end instrumentation.
- Ongoing biotech sector consolidation—facility reductions and mergers continue to make late-model equipment available from leading companies in major innovation hubs.
- Scheduled university and core-facility refresh cycles—many R1 institutions are upgrading 5–8-year-old systems, even as the existing instruments remain fully operational and often under extended service contracts.
The outcome: unprecedented availability of premium used lab equipment at historically low price points.
Early indicators already reflect this trend:
- Illumina NovaSeq systems (original list ~$985,000) trading in the $280,000–$350,000 range.
- BD FACSAria and CytoFLEX flow cytometers available 60–70% below new pricing.
- Thermo Fisher Vanquish UHPLC platforms from recent projects listed under $70,000.
- Large inventories of –80°C freezers and biosafety cabinets from single-site liquidations.
This surplus represents instruments maintained to rigorous standards in controlled environments—not end-of-life assets, but technology with years of productive service remaining.
For lab managers and procurement teams planning 2026 capital expenditures, preparation is key:
- Build detailed wish lists with model numbers, required accessories, and budget parameters.
- Set up saved searches and notifications on specialized platforms.
- Secure internal approvals in advance to move quickly when ideal matches appear.
- Partner with platforms that provide verification, documentation, and logistics support.
The strongest opportunities will likely concentrate in the first half of 2026, before absorption by growing programs stabilizes pricing.
Labs that position themselves now will gain a meaningful competitive advantage—accessing cutting-edge capability sooner and at lower cost than peers relying solely on new purchases.
ScienceLiquidation.com offers real-time alerts, verified listings, and direct access to this incoming wave of inventory.
Create your account and configure notifications today to capture the best of what 2026 has to offer.
